Literature DB >> 11179155

Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study.

S Illi1, E von Mutius, S Lau, R Bergmann, B Niggemann, C Sommerfeld, U Wahn.   

Abstract

OBJECTIVE: To investigate the association between early childhood infections and subsequent development of asthma.
DESIGN: Longitudinal birth cohort study.
SETTING: Five children's hospitals in five German cities. PARTICIPANTS: 1314 children born in 1990 followed from birth to the age of 7 years. MAIN OUTCOME MEASURES: Asthma and asthmatic symptoms assessed longitudinally by parental questionnaires; atopic sensitisation assessed longitudinally by determination of IgE concentrations to various allergens; bronchial hyperreactivity assessed by bronchial histamine challenge at age 7 years.
RESULTS: Compared with children with </=1 episode of runny nose before the age of 1 year, those with >/=2 episodes were less likely to have a doctor's diagnosis of asthma at 7 years old (odds ratio 0.52 (95% confidence interval 0.29 to 0.92)) or to have wheeze at 7 years old (0.60 (0.38 to 0.94)), and were less likely to be atopic before the age of 5 years. Similarly, having >/=1 viral infection of the herpes type in the first 3 years of life was inversely associated with asthma at age 7 (odds ratio 0.48 (0.26 to 0.89)). Repeated lower respiratory tract infections in the first 3 years of life showed a positive association with wheeze up to the age of 7 years (odds ratio 3.37 (1.92 to 5.92) for >/=4 infections v </=3 infections).
CONCLUSION: Repeated viral infections other than lower respiratory tract infections early in life may reduce the risk of developing asthma up to school age.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179155      PMCID: PMC26566          DOI: 10.1136/bmj.322.7283.390

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  15 in total

1.  Family size, childhood infections and atopic diseases. The Aberdeen WHEASE Group.

Authors:  C Bodner; D Godden; A Seaton
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

2.  Atopic diseases in infancy. The German multicenter atopy study (MAS-90).

Authors:  R L Bergmann; K E Bergmann; S Lau-Schadensdorf; W Luck; A Dannemann; C P Bauer; W Dorsch; J Forster; E Schmidt; J Schulz
Journal:  Pediatr Allergy Immunol       Date:  1994       Impact factor: 6.377

3.  Reactivity to cold-air hyperventilation in normal and in asthmatic children in a survey of 5,697 schoolchildren in southern Bavaria.

Authors:  T Nicolai; E V Mutius; P Reitmeir; M Wjst
Journal:  Am Rev Respir Dis       Date:  1993-03

4.  Skin test reactivity and number of siblings.

Authors:  E von Mutius; F D Martinez; C Fritzsch; T Nicolai; P Reitmeir; H H Thiemann
Journal:  BMJ       Date:  1994-03-12

5.  Early childhood infection and atopic disorder.

Authors:  I S Farooqi; J M Hopkin
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

6.  The association of family size with atopy and atopic disease.

Authors:  D Jarvis; S Chinn; C Luczynska; P Burney
Journal:  Clin Exp Allergy       Date:  1997-03       Impact factor: 5.018

7.  Measles and atopy in Guinea-Bissau.

Authors:  S O Shaheen; P Aaby; A J Hall; D J Barker; C B Heyes; A W Shiell; A Goudiaby
Journal:  Lancet       Date:  1996-06-29       Impact factor: 79.321

8.  Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus.

Authors:  P M Matricardi; F Rosmini; L Ferrigno; R Nisini; M Rapicetta; P Chionne; T Stroffolini; P Pasquini; R D'Amelio
Journal:  BMJ       Date:  1997-04-05

9.  Age of entry to day nursery and allergy in later childhood.

Authors:  U Krämer; J Heinrich; M Wjst; H E Wichmann
Journal:  Lancet       Date:  1999-02-06       Impact factor: 79.321

10.  Association of non-wheezing lower respiratory tract illnesses in early life with persistently diminished serum IgE levels. Group Health Medical Associates.

Authors:  F D Martinez; D A Stern; A L Wright; L M Taussig; M Halonen
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

View more
  110 in total

1.  The protective effect of childhood infections.

Authors:  S L Johnston; P J Openshaw
Journal:  BMJ       Date:  2001-02-17

2.  Asthma and early childhood infectious disease. Infection is trigger rather than cause.

Authors:  V Angelakou; M Bitsori; E Galanakis
Journal:  BMJ       Date:  2001-07-21

3.  Age at childhood infections and risk of atopy.

Authors:  P Bager; T Westergaard; K Rostgaard; H Hjalgrim; M Melbye
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 4.  Allergen exposure and the development of asthma.

Authors:  R Sporik; T A Platts-Mills
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

5.  Airway function at one year: association with premorbid airway function, wheezing, and maternal smoking.

Authors:  C Dezateux; J Stocks; A M Wade; I Dundas; M E Fletcher
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 6.  Pro and anti: the biotics of allergic disease.

Authors:  J Crane
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

7.  Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood.

Authors:  Catherine Cohet; Soo Cheng; Claire MacDonald; Michael Baker; Sunia Foliaki; Nyk Huntington; Jeroen Douwes; Neil Pearce
Journal:  J Epidemiol Community Health       Date:  2004-10       Impact factor: 3.710

Review 8.  Role of adenoidectomy in otitis media and respiratory function.

Authors:  Petri S Mattila
Journal:  Curr Allergy Asthma Rep       Date:  2010-11       Impact factor: 4.806

9.  Childhood infections and risk of wheezing and allergic sensitisation at age 7-8 years.

Authors:  Monique Mommers; Gerard M H Swaen; Michaela Weishoff-Houben; Huub Creemers; Hermann Freund; Wolfgang Dott; Constant P van Schayck
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 10.  The pharmacological modulation of allergen-induced asthma.

Authors:  L L Ma; Paul M O'Byrne
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.